Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Gabelli 18th Annual Sports & Media Symposium Agenda Released

May 14, 2026

BranchOut Food Shareholder Update: Record Production and Major Customer Deliveries Position Company for Record Q2

May 14, 2026

BitFuFu Announces April 2026 Bitcoin Production and Operational Updates

May 14, 2026

Jackery Brings the Power and Savings to Memorial Day Weekend

May 14, 2026

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

May 14, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » KFSHRC Celebrates 40 Years of Stem Cell Leadership at GHE 2024
Press Release

KFSHRC Celebrates 40 Years of Stem Cell Leadership at GHE 2024

By News RoomOctober 22, 20242 Mins Read
KFSHRC Celebrates 40 Years of Stem Cell Leadership at GHE 2024
Share
Facebook Twitter LinkedIn Pinterest Email

RIYADH, Saudi Arabia, Oct. 22, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSHRC) celebrated the 40th anniversary of its Stem Cell program, a regional leader in bone marrow and stem cell transplantation. Ranked within the top 2% facilities worldwide for the volume of annual stem cell transplants, the Centre had successfully performed more than 7,400 transplants, 38% of which for pediatric patients. The achievement was recognized during the 2024 Global Health Exhibition.

Four decades of pioneering medical achievement have positioned the Stem Cell Centre as one of the largest globally for bone marrow transplants, according to the Center for International Blood & Marrow Transplant Research CIBMTR in Wisconsin, USA. The Centre offers all internationally recognized bone marrow transplant types, including autologous transplants, matched (syngeneic) and half-matched (haploidentical) donor transplants, and umbilical cord blood transplants. These procedures have helped treat numerous complex cases, enhancing the quality of life for patients.

The KFSHRC Stem Cell Center has been instrumental in founding the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group, which promotes and advances research and transplantation programs across the Middle East. The Centre has also published more than 500 research papers and actively supports region-specific research and statistical studies.

KFSHRC’s Stem Cell Centre was the first medical centre outside North America and Europe to receive accreditation from the Joint Accreditation Committee ISCT & EBMT (JACIE) in 2010.

Stem cell transplants are used to treat a wide range of diseases, including leukemia, lymphoma, bone marrow failure, severe combined immunodeficiency (SCID), sickle cell anemia, thalassemia, and multiple myeloma.

It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year and recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world’s best 250 hospitals and included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit www.kfshrc.edu.sa or contact our media team at [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1a4ed70c-28ed-4c97-86b2-a9edb9c4ad01

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Gabelli 18th Annual Sports & Media Symposium Agenda Released

BranchOut Food Shareholder Update: Record Production and Major Customer Deliveries Position Company for Record Q2

BitFuFu Announces April 2026 Bitcoin Production and Operational Updates

Jackery Brings the Power and Savings to Memorial Day Weekend

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers

PruittHealth Certified as a Great Place to Work for Fifth Consecutive Year

AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer

Editors Picks

BranchOut Food Shareholder Update: Record Production and Major Customer Deliveries Position Company for Record Q2

May 14, 2026

BitFuFu Announces April 2026 Bitcoin Production and Operational Updates

May 14, 2026

Jackery Brings the Power and Savings to Memorial Day Weekend

May 14, 2026

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

May 14, 2026

Latest News

EV, hybrid sales 75% higher than March 2025 as gas prices near records

May 14, 2026

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

May 14, 2026

Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers

May 14, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version